Static Chart Daxor Corporation Nyse

Equities

Delayed Nyse Other stock markets 02:00:00 27/06/2024 am IST			5-day change	1st Jan Change
9.59 ^USD	+2.46%		+8.61%	-0.10%

05/06	Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer	CI
16/04	Daxor Corporation Announces Two New Studies Validating the Clinical Benefits of Daxor?s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion	CI

Duration

Period